271 related articles for article (PubMed ID: 16980556)
1. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization.
Moore RH; Millman EE; Godines V; Hanania NA; Tran TM; Peng H; Dickey BF; Knoll BJ; Clark RB
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):254-61. PubMed ID: 16980556
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor.
January B; Seibold A; Allal C; Whaley BS; Knoll BJ; Moore RH; Dickey BF; Barber R; Clark RB
Br J Pharmacol; 1998 Feb; 123(4):701-11. PubMed ID: 9517390
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
Gimenez LE; Baameur F; Vayttaden SJ; Clark RB
Mol Pharmacol; 2015 Jun; 87(6):954-64. PubMed ID: 25784721
[TBL] [Abstract][Full Text] [Related]
4. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
[TBL] [Abstract][Full Text] [Related]
5. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
[TBL] [Abstract][Full Text] [Related]
6. Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha).
Finney PA; Donnelly LE; Belvisi MG; Chuang TT; Birrell M; Harris A; Mak JC; Scorer C; Barnes PJ; Adcock IM; Giembycz MA
Br J Pharmacol; 2001 Mar; 132(6):1261-70. PubMed ID: 11250877
[TBL] [Abstract][Full Text] [Related]
7. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
Clark RB; Allal C; Friedman J; Johnson M; Barber R
Mol Pharmacol; 1996 Jan; 49(1):182-9. PubMed ID: 8569705
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.
Slack RJ; Barrett VJ; Morrison VS; Sturton RG; Emmons AJ; Ford AJ; Knowles RG
J Pharmacol Exp Ther; 2013 Jan; 344(1):218-30. PubMed ID: 23131596
[TBL] [Abstract][Full Text] [Related]
9. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors.
Lin FT; Chen W; Shenoy S; Cong M; Exum ST; Lefkowitz RJ
Biochemistry; 2002 Aug; 41(34):10692-9. PubMed ID: 12186555
[TBL] [Abstract][Full Text] [Related]
11. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells.
Chien JW; Chu YT; Yang SN; Kuo CH; Wang WL; Kuo PL; Jong YJ; Hung CH
J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of glycyrrhizin against β₂-adrenergic receptor agonist-induced receptor internalization and cell apoptosis.
Shi Q; Hou Y; Yang Y; Bai G
Biol Pharm Bull; 2011; 34(5):609-17. PubMed ID: 21532146
[TBL] [Abstract][Full Text] [Related]
14. beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists.
January B; Seibold A; Whaley B; Hipkin RW; Lin D; Schonbrunn A; Barber R; Clark RB
J Biol Chem; 1997 Sep; 272(38):23871-9. PubMed ID: 9295336
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic beta-agonist-promoted receptor conformations and signals independent of intrinsic activity.
Swift SM; Schwarb MR; Mihlbachler KA; Liggett SB
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):236-43. PubMed ID: 16980553
[TBL] [Abstract][Full Text] [Related]
17. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex.
Naga Prasad SV; Laporte SA; Chamberlain D; Caron MG; Barak L; Rockman HA
J Cell Biol; 2002 Aug; 158(3):563-75. PubMed ID: 12163475
[TBL] [Abstract][Full Text] [Related]
18. Differential phosphorylation and dephosphorylation of beta2-adrenoceptor sites Ser262 and Ser355,356.
Iyer V; Tran TM; Foster E; Dai W; Clark RB; Knoll BJ
Br J Pharmacol; 2006 Feb; 147(3):249-59. PubMed ID: 16331289
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of phosphoinositide 3-kinase cause defects in the postendocytic sorting of beta2-adrenergic receptors.
Awwad HO; Iyer V; Rosenfeld JL; Millman EE; Foster E; Moore RH; Knoll BJ
Exp Cell Res; 2007 Jul; 313(12):2586-96. PubMed ID: 17553490
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
Lindén A; Rabe KF; Löfdahl CG
Lung; 1996; 174(1):1-22. PubMed ID: 8746998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
